Analysis of prognostic factors in 568 patients treated for breast cancer by surgery

dc.contributor.authorMuller, A.G.S.
dc.contributor.authorVan Zyl, J.A.
dc.contributor.authorJoubert, G.
dc.contributor.authorMuller, A.G.S.
dc.contributor.authorVan Zyl, J.A.
dc.contributor.authorJoubert, G.
dc.date.accessioned2011-05-15T16:17:09Z
dc.date.accessioned2011-05-15T16:17:09Z
dc.date.available2011-05-15T16:17:09Z
dc.date.available2011-05-15T16:17:09Z
dc.date.issued1989
dc.date.issued1989
dc.description.abstractThe Tygerberg Breast Clinic serves a heterogeneous population, and it is therefore possible to analyse prognostic factors influencing survival and to identify any possible differences between these groups. From 1978 to 1985, 568 breast cancer patients (52% white and 48% colored) were treated surgically in Tygerberg Hospital. Stage for stage, all patients received identical treatment. Colored patients were seen at a younger age, with more advanced disease, had lower estrogen receptor values, and more nodes involved. Cox's regression analysis of age, receptor value, stage, nodal involvement, race, menopausal status, treatment, and study period in the evaluation of disease-free survival and overall survival confirmed stage and lymph node status as prognostic factors. Estrogen receptor status, menopausal status, age at presentation, treatment, study period, and race did not enter the regression, except in stage I, where race was a variable. A target group for directing educational intervention is identified.
dc.description.abstractThe Tygerberg Breast Clinic serves a heterogeneous population, and it is therefore possible to analyse prognostic factors influencing survival and to identify any possible differences between these groups. From 1978 to 1985, 568 breast cancer patients (52% white and 48% colored) were treated surgically in Tygerberg Hospital. Stage for stage, all patients received identical treatment. Colored patients were seen at a younger age, with more advanced disease, had lower estrogen receptor values, and more nodes involved. Cox's regression analysis of age, receptor value, stage, nodal involvement, race, menopausal status, treatment, and study period in the evaluation of disease-free survival and overall survival confirmed stage and lymph node status as prognostic factors. Estrogen receptor status, menopausal status, age at presentation, treatment, study period, and race did not enter the regression, except in stage I, where race was a variable. A target group for directing educational intervention is identified.
dc.description.versionArticle
dc.description.versionArticle
dc.identifier.citationJournal of Surgical Oncology
dc.identifier.citation42
dc.identifier.citation2
dc.identifier.citationJournal of Surgical Oncology
dc.identifier.citation42
dc.identifier.citation2
dc.identifier.issn00224790
dc.identifier.issn00224790
dc.identifier.urihttp://hdl.handle.net/10019.1/14093
dc.identifier.urihttp://hdl.handle.net/10019.1/14093
dc.subjectadult; aged; breast cancer; female; human; major clinical study; priority journal; prognosis; Breast Neoplasms; Female; Follow-Up Studies; Human; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Age; Neoplasm Staging; Prognosis; Racial Stocks; Risk Factors; Support, Non-U.S. Gov't
dc.subjectadult
dc.subjectaged
dc.subjectbreast cancer
dc.subjectfemale
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectpriority journal
dc.subjectprognosis
dc.subjectBreast Neoplasms
dc.subjectFemale
dc.subjectFollow-Up Studies
dc.subjectHuman
dc.subjectLymphatic Metastasis
dc.subjectMastectomy, Modified Radical
dc.subjectMiddle Age
dc.subjectNeoplasm Staging
dc.subjectPrognosis
dc.subjectRacial Stocks
dc.subjectRisk Factors
dc.subjectSupport, Non-U.S. Gov't
dc.titleAnalysis of prognostic factors in 568 patients treated for breast cancer by surgery
dc.titleAnalysis of prognostic factors in 568 patients treated for breast cancer by surgery
Files